IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5%
IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5%
Discontinued
DIN Number
02230919
Drug Class
Human
Market Date
Nov 3, 1997
Company
HC
TALECRIS BIOTHERAPEUTICS INC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02230919
AIG Number0106267014
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BA02 IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASC. ADM.
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification80:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
IMMUNOGLOBULIN (HUMAN)Active
Strength: 5 G / 100 ML
Monograph: IMMUNOGLOBULIN (HUMAN)